目前关于益生菌使用的监管问题
Hania Szajewska1, Gabriel Vinderola2
1Department of Paediatrics, The Medical University of Warsaw, Warsaw, Poland. hszajewska@wum.edu.pl.
Advances in experimental medicine and biology
|July 26, 2024
概括
全球益生菌法规面临由于区域不一致的挑战. 协调指导方针和改进产品标签对于安全有效地使用益生菌至关重要,特别是对于弱势群体.
科学领域:
- 微生物学 微生物学
- 监管科学 监管科学
- 食品科学 食品科学 食品科学
背景情况:
- 益生菌提供健康益处,但面临复杂的全球监管障碍.
- 各地区不一致的法规给消费者,医疗保健专业人员和行业带来了挑战.
- 人们越来越认识到对标准化指南的需求.
研究的目的:
- 提供有关益生菌当前监管挑战的概述.
- 突出全球监管协调的努力.
- 强调准确标签和安全评估的重要性.
主要方法:
- 对益生菌的全球监管格局的审查.
- 分析监管不一致及其影响.
- 审查诸如食品法典 (Codex Alimentarius) 这样的倡议,以制定指导方针.
- 讨论标签和安全评估要求.
主要成果:
- 在益生菌法规中存在显著的区域差异.
- 不一致的法规阻碍了基于证据的决策和市场准入.
- 目前正在努力通过国际机构协调指南.
- 标签和安全问题,特别是对弱势群体,需要注意.
结论:
- 在全球范围内协调益生菌法规至关重要.
- 标准化的指导方针将促进更安全,更有效的益生菌利用.
- 准确的标签和强大的安全评估对于消费者信任和公共健康至关重要.
相关概念视频
01:25Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
01:21Drugs for Treatment of Constipation-Predominant IBS
151
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
151
01:03Drug Control Governance: Regulatory Bodies and Their Impact
148
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
148
01:19Pharmacovigilance
805
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
805
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
384
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
384